Cargando…

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies

OBJECTIVES: The purpose of this study is to evaluate the diagnostic accuracy of the clinical variables of patients with prostate cancer (PCa) and to provide a strategy to reduce unnecessary biopsies. PATIENTS AND METHODS: A Chinese cohort that consists of 833 consecutive patients who underwent prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Changming, Yuan, Lei, Shen, Deyun, Zhang, Bin, Wu, Baorui, Zhang, Panrui, Xiao, Jun, Tao, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709422/ https://www.ncbi.nlm.nih.gov/pubmed/36465344 http://dx.doi.org/10.3389/fonc.2022.1024204

Ejemplares similares

The Value of Low Prostate Imaging—Reporting and Data System (PI-RADS) Scores in Preventing Unnecessary Prostate Biopsies
por: Kim, Dong-Soo, et al.
Publicado: (2021)

Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution
por: Nan, Li-Bin, et al.
Publicado: (2019)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
por: Yu, Shuanbao, et al.
Publicado: (2020)

Can a prostate biopsy be safely deferred on PI-RADS 1,2 or 3 lesions seen on pre-biopsy mp-MRI?
por: Abdul Raheem, Rickaz, et al.
Publicado: (2022)

Diagnostic performance of transperineal prostate targeted biopsy alone according to the PI-RADS score based on bi-parametric magnetic resonance imaging
por: Noh, Tae Il, et al.
Publicado: (2023)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies
por: Wang, Yunhan, et al.
Publicado: (2023)

Ultrasound‐based radiomics score for pre‐biopsy prediction of prostate cancer to reduce unnecessary biopsies
por: Ou, Wei, et al.
Publicado: (2022)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
por: Gaudiano, Caterina, et al.
Publicado: (2023)

Machine learning-based analysis of a semi-automated PI-RADS v2.1 scoring for prostate cancer
por: Singh, Dharmesh, et al.
Publicado: (2022)

Impact of PI-RADS v2 on indication of prostate biopsy
por: Rozas, George de Queiroz, et al.
Publicado: (2019)

The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3
por: Zhu, Hai, et al.
Publicado: (2022)

Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer
por: Li, Mou, et al.
Publicado: (2021)

Study of iron metabolism based on T2* mapping sequences in PI-RADS 3 prostate lesions
por: D, Wenhao, et al.
Publicado: (2023)

Looking back on 25 years of the PSAD study group
por: Snoek, F. J.
Publicado: (2019)

Developing Strategy to Predict the Results of Prostate Multiparametric Magnetic Resonance Imaging and Reduce Unnecessary Multiparametric Magnetic Resonance Imaging Scan
por: Liu, Junxiao, et al.
Publicado: (2021)

Using the Prostate Imaging Reporting and Data System version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment
por: Liu, Chang, et al.
Publicado: (2018)

Combination of ultrafast dynamic contrast-enhanced MRI-based radiomics and artificial neural network in assessing BI-RADS 4 breast lesions: Potential to avoid unnecessary biopsies
por: Lyu, Yidong, et al.
Publicado: (2023)

Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores
por: Tomioka, Masayuki, et al.
Publicado: (2023)

Development of a measure of prescriber satisfaction with academic detailing: the PSAD
por: Monteiro, Andrea L, et al.
Publicado: (2022)

Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
por: Li, Tianping, et al.
Publicado: (2022)

Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?
por: Gomez-Gomez, Enrique, et al.
Publicado: (2021)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

Construction and Validation of a Clinical Predictive Nomogram for Improving the Cancer Detection of Prostate Naive Biopsy Based on Chinese Multicenter Clinical Data
por: Tao, Tao, et al.
Publicado: (2022)

TRUS-Guided Target Biopsy for a PI-RADS 3–5 Index Lesion to Reduce Gleason Score Underestimation: A Propensity Score Matching Analysis
por: Chung, Jae Hoon, et al.
Publicado: (2022)

Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?
por: Wei, Cheng, et al.
Publicado: (2021)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022)

Primary follicular lymphoma of the prostate presenting with elevated PSA and a PI-RADS 3 lesion on MRI: A case report
por: Jia, Hanna, et al.
Publicado: (2022)

A Prospective Study of Reducing Unnecessary Prostate Biopsy in Patients with High Serum Prostate-Specific Antigen with Consideration of Prostatic Inflammation
por: Lee, An Gu, et al.
Publicado: (2012)

MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies
por: Zhang, Li, et al.
Publicado: (2022)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
por: Bertok, Tomas, et al.
Publicado: (2020)

Metastasectomy for rectal wall seeding of prostate adenocarcinoma after transrectal prostate biopsy
por: DiLizia, E Matthew, et al.
Publicado: (2020)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
por: Vickers, Andrew J, et al.
Publicado: (2008)

Value of an online PI-RADS v2.1 score calculator for assessment of prostate MRI
por: Barth, Borna K., et al.
Publicado: (2021)

PI‐RADS 3 score: A retrospective experience of clinically significant prostate cancer detection
por: Camacho, Andrés, et al.
Publicado: (2023)

An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy
por: Zhao, Hao, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
por: Huang, Da, et al.
Publicado: (2020)

Application of single-point prostate biopsy in elderly patients with highly suspected prostate cancer
por: Luan, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nbjikc60c6bhqtd3obqbsneia9